
21/07/2025
📢 Massive transition underway in drugmaking! Our latest article dives into how AI is moving from "fringe to frontier" in biopharma, becoming a core tool in drug discovery and development.
Featuring insights from Dr. Lynda Stuart of FFST, Dr. Mathai Mammen of Parabilis Medicines, and Matt Truppo of Sanofi, we explore:
🔬 How AI is drastically cutting research times
💡 Overcoming resistance to adopting new tech
⚖️ Balancing rapid innovation with responsible use and ethics
It's an exciting, complex time for the industry. Learn how leaders are navigating this shift and building for a future where human insight and AI's capabilities are integrated for better patient well-being. Visit https://pharmaleaders.com/ai-in-biopharma-navigating-the-massive-transition-in-drugmaking-leadership/ to learn more.
From Fringe to Frontier: AI as a Core Tool Dr. Lynda Stuart, CEO of the Fund for Science and Technol